New Delhi, May 11 -- GLP-1 drugs like Ozempic, Wegovy and Mounjaro have become incredibly powerful tools for weight loss. While they do suppress appetite and help people shed weight, the cost at which this comes is important to consider.

It's essential to look beyond short-term outcomes. In an interview with HT Lifestyle, Dr Kalpana Gupta Shekhawat, Functional and Metabolic Medicine Specialist, shared, "With GLP-1 drugs, the risks are real-there have been observed cases of muscle loss, nutrient deficiencies and slower gut motility. Many individuals experience significant nausea, making it difficult to get through the day. Gallbladder issues have also been reported. In some patients, pancreatitis has developed, and early data has raised c...